Odonate Therapeutics Inc (ODT)
Common Stock
| TTM (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -102.07M | -126.35M | -111.83M | -88.96M | -32.74M | |||
| Depreciation Amortization | 498.00K | 450.00K | 380.00K | 350.00K | 20.00K | |||
| Change In Working Capital | -133.00K | 2.44M | 3.36M | 14.73M | 1.87M | |||
| Other non cash items | 7.17M | 10.34M | 11.44M | 6.79M | 5.00M | |||
| OPERATING CASH FLOW | -94.54M | -113.13M | -96.64M | -67.09M | -25.86M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -36.00K | -430.00K | -170.00K | -1.91M | -80.00K | |||
| INVESTING CASH FLOW | -36.00K | -430.00K | -170.00K | -1.91M | -80.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 1.35M | 90.37M | 138.68M | 10.20M | 221.45M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 1.35M | 90.37M | 138.68M | 10.20M | 221.45M | |||
| CHANGE IN CASH | -93.22M | -23.19M | 41.87M | -58.80M | 195.51M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -94.54M | -113.13M | -96.64M | -67.09M | -25.86M | |||
| Capital Expenditure | -36.00K | -430.00K | -170.00K | -1.91M | -80.00K | |||
| FREE CASH FLOW | -94.57M | -113.56M | -96.81M | -69.00M | -25.94M | |||
All data in USD